Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Erectile Dysfunction Drugs market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Erectile Dysfunction Drugs market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Erectile Dysfunction Drugs market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Erectile Dysfunction Drugs products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Erectile Dysfunction Drugs products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Erectile Dysfunction Drugs market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Erectile Dysfunction Drugs development has been the leading industry trend of Erectile Dysfunction Drugs market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Erectile Dysfunction Drugs Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Sildenafil,Tadalafil,Others |
| By Application Outlook |
Hospital Pharmacies,Private Clinics,Retail Pharmacies,E-Commerce (B2B),E-Commerce (B2C) |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Eli Lilly,Pfizer,Bayer,BaiYunShan General Factory,S.K. Chemicals,Teva Pharma,Dong-A ST,Metuchen Pharma,Seoul Pharma,CSBIO. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Eli Lilly
- Pfizer
- Bayer
- BaiYunShan General Factory
- S.K. Chemicals
- Teva Pharma
- Dong-A ST
- Metuchen Pharma
- Seoul Pharma
- CSBIO.
Erectile Dysfunction Drugs Market, By Type
- Sildenafil
- Tadalafil
- Others
Erectile Dysfunction Drugs Market, By Application
- Hospital Pharmacies
- Private Clinics
- Retail Pharmacies
- E-Commerce (B2B)
- E-Commerce (B2C)
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Global Erectile Dysfunction Drugs Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Erectile Dysfunction Drugs Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Erectile Dysfunction Drugs Industry Overview
2.1 Global Erectile Dysfunction Drugs Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Erectile Dysfunction Drugs Global Import Market Analysis
2.1.2 Erectile Dysfunction Drugs Global Export Market Analysis
2.1.3 Erectile Dysfunction Drugs Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3.2 Private Clinics
2.3.3 Retail Pharmacies
2.3.4 E-Commerce (B2B)
2.3.5 E-Commerce (B2C)
2.4.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Erectile Dysfunction Drugs Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Erectile Dysfunction Drugs Manufacturer Market Share
2.4.5 Top 10 Erectile Dysfunction Drugs Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Erectile Dysfunction Drugs Market
2.4.7 Key Manufacturers Erectile Dysfunction Drugs Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Erectile Dysfunction Drugs Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Erectile Dysfunction Drugs Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Erectile Dysfunction Drugs Market Size Categorized by Regions
4.1 Global Erectile Dysfunction Drugs Revenue, Sales and Market Share by Regions
4.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Regions (2015-2020)
4.2 Europe Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.3 APAC Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.4 North America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.5 South America Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5 Europe Erectile Dysfunction Drugs Market Size Categorized by Countries
5.1 Europe Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
5.1.1 Europe Erectile Dysfunction Drugs Sales by Countries (2015-2020)
5.1.2 Europe Erectile Dysfunction Drugs Revenue by Countries (2015-2020)
5.1.3 Germany Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.1.4 UK Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.1.5 France Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.1.6 Russia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.1.7 Italy Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.1.8 Spain Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
5.2 Europe Erectile Dysfunction Drugs Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
5.3.2 Europe Erectile Dysfunction Drugs Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
6 Asia-Pacific Erectile Dysfunction Drugs Market Size Categorized by Countries
6.1 Asia-Pacific Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Erectile Dysfunction Drugs Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Erectile Dysfunction Drugs Revenue by Countries (2015-2020)
6.1.3 China Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.1.4 Japan Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.1.5 Korea Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.1.6 India Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.1.8 Australia Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Erectile Dysfunction Drugs Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Erectile Dysfunction Drugs Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Erectile Dysfunction Drugs Sales and Market Share by Application (2015-2020)
7 North America Erectile Dysfunction Drugs Market Size Categorized by Countries
7.1 North America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
7.1.1 North America Erectile Dysfunction Drugs Sales by Countries (2015-2020)
7.1.2 North America Erectile Dysfunction Drugs Revenue by Countries (2015-2020)
7.1.3 United States Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.1.4 Canada Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.1.5 Mexico Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
7.2 North America Erectile Dysfunction Drugs Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
7.3.2 North America Erectile Dysfunction Drugs Revenue and Revenue Share by Type (2015-2020)
7.4 North America Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
8 South America Erectile Dysfunction Drugs Market Size Categorized by Countries
8.1 South America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Erectile Dysfunction Drugs Sales by Countries (2015-2020)
8.1.2 South America Erectile Dysfunction Drugs Revenue by Countries (2015-2020)
8.1.3 Brazil Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
8.2 South America Erectile Dysfunction Drugs Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
8.3.2 South America Erectile Dysfunction Drugs Revenue and Revenue Share by Type (2015-2020)
8.4 South America Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
9 Middle East and Africa Erectile Dysfunction Drugs Market Size Categorized by Countries
9.1 Middle East and Africa Erectile Dysfunction Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Countries (2015-2020)
9.1.3 GCC Countries Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.1.4 Turkey Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.1.5 Egypt Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.1.6 South Africa Erectile Dysfunction Drugs Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Erectile Dysfunction Drugs Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Erectile Dysfunction Drugs Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Erectile Dysfunction Drugs Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2015-2020)
10 Global Erectile Dysfunction Drugs Market Segment by Type
10.1 Global Erectile Dysfunction Drugs Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Erectile Dysfunction Drugs Sales and Market Share by Type (2015-2020)
10.1.2 Global Erectile Dysfunction Drugs Revenue and Market Share by Type (2015-2020)
10.2 Sildenafil Sales Growth Rate and Price
10.2.1 Global Sildenafil Sales Growth Rate (2015-2020)
10.2.2 Global Sildenafil Price (2015-2020)
10.3 Tadalafil Sales Growth Rate and Price
10.3.1 Global Tadalafil Sales Growth Rate (2015-2020)
10.3.2 Global Tadalafil Price (2015-2020)
10.4 Others Sales Growth Rate and Price
10.4.1 Global Others Sales Growth Rate (2015-2020)
10.4.2 Global Others Price (2015-2020)
11.1 Global Erectile Dysfunction DrugsSales Market Share by Application (2015-2020)
11.2 Hospital Pharmacies Sales Growth Rate (2015-2020)
11.3 Private Clinics Sales Growth Rate (2015-2020)
11.4 Retail Pharmacies Sales Growth Rate (2015-2020)
11.5 E-Commerce (B2B) Sales Growth Rate (2015-2020)
11.6 E-Commerce (B2C) Sales Growth Rate (2015-2020)
12.1 Global Erectile Dysfunction Drugs Revenue, Sales and Growth Rate (2020-2027)
12.2 Erectile Dysfunction Drugs Market Forecast by Regions (2020-2027)
12.2.1 Europe Erectile Dysfunction Drugs Market Forecast (2020-2027)
12.2.2 APAC Erectile Dysfunction Drugs Market Forecast (2020-2027)
12.2.3 North America Erectile Dysfunction Drugs Market Forecast (2020-2027)
12.2.4 South America Erectile Dysfunction Drugs Market Forecast (2020-2027)
12.2.5 Middle East & Africa Erectile Dysfunction Drugs Market Forecast (2020-2027)
12.3 Erectile Dysfunction Drugs Market Forecast by Type (2020-2027)
12.3.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2020-2027)
12.3.2 Global Erectile Dysfunction Drugs Market Share Forecast by Type (2020-2027)
12.4 Erectile Dysfunction Drugs Market Forecast by Application (2020-2027)
12.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2020-2027)
12.4.2 Global Erectile Dysfunction Drugs Market Share Forecast by Application (2020-2027)
13 Analysis of Erectile Dysfunction Drugs Industry Key Manufacturers
13.1 Eli Lilly
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Eli Lilly Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Eli Lilly News
13.2 Pfizer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Pfizer Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Pfizer News
13.3 Bayer
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Bayer Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Bayer News
13.4 BaiYunShan General Factory
13.4.1 Company Details
13.4.2 Product Information
13.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 BaiYunShan General Factory News
13.5 S.K. Chemicals
13.5.1 Company Details
13.5.2 Product Information
13.5.3 S.K. Chemicals Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 S.K. Chemicals News
13.6 Teva Pharma
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Teva Pharma Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Teva Pharma News
13.7 Dong-A ST
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Dong-A ST Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Dong-A ST News
13.8 Metuchen Pharma
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Metuchen Pharma Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Metuchen Pharma News
13.9 Seoul Pharma
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Seoul Pharma Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Seoul Pharma News
13.10 CSBIO.
13.10.1 Company Details
13.10.2 Product Information
13.10.3 CSBIO. Erectile Dysfunction Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 CSBIO. News
15 Appendix
